{
    "clinical_study": {
        "@rank": "119250", 
        "arm_group": [
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "No Intervention", 
                "description": "Obese, otherwise healthy people who are not receiving any nutritional,surgical or behavioral therapy"
            }, 
            {
                "arm_group_label": "Weight loss group", 
                "arm_group_type": "Active Comparator", 
                "description": "Full Meal replacement Protocol"
            }
        ], 
        "brief_summary": {
            "textblock": "The main purpose of this study is to assess factors mediating the changes in insulin\n      sensitivity and glucose tolerance before and after 10 lbs \u00b1 or 2% weight loss reduction as\n      well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet.\n\n      The investigators will also study the following:\n\n        1. The impact of diet induced weight loss on hormones/adipokine levels\n\n        2. The impact of diet induced weight loss on leptin tolerance"
        }, 
        "brief_title": "Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity", 
            "Weight Loss"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Insulin Resistance", 
                "Obesity", 
                "Weight Loss"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for interventional group:\n\n          1. Adult men and women, age 18-50\n\n          2. English speaking\n\n          3. Body mass index (pre weight loss) \u226530 kg/m2 but <40 kg/m2\n\n          4. Willing to enroll in a low calorie full meal replacement weight loss program\n\n          5. Willing and able to take part in a multi year study involving visits\n\n        Inclusion Criteria for control group:\n\n          1. Adult men and women, age 18-50\n\n          2. English speaking\n\n          3. Body mass index (pre weight loss) \u226530 kg/m2 but <40 kg/m2\n\n          4. Willing and able to take part in a multi year study involving visits"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01780870", 
            "org_study_id": "2011P-000293"
        }, 
        "intervention": {
            "arm_group_label": "Weight loss group", 
            "description": "In the intervention arm of this non randomized, open label study to assess the effects of weight loss on insulin sensitivity and leptin tolerance subjects will use full meal replacement products (1280-1320kcal/day). Subjects will be on the full meal replacement products only, for the first 12 weeks, between 13 to 19 weeks they will be transitioned to regular food, from 19 weeks and going forward they will be on chronic maintenance phase", 
            "intervention_name": "Weight loss group (Full meal replacement products)", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Full meal replacement products (1280-1320 kcal/day)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Overweight", 
            "Obesity", 
            "Obese", 
            "Weight loss"
        ], 
        "lastchanged_date": "February 19, 2013", 
        "location": {
            "contact": {
                "email": "mantzlab@bidmc.harvard.edu", 
                "last_name": "Christos Mantzoros, MD", 
                "phone": "617-667-8630"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Beth Israel Deaconess Medical Center"
            }, 
            "investigator": {
                "last_name": "Christos Mantzoros, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss", 
        "overall_contact": {
            "email": "mantzlab@bidmc.harvard.edu", 
            "last_name": "Christos Mantzoros, MD", 
            "phone": "617-667-8630"
        }, 
        "overall_official": {
            "affiliation": "Beth Israel Deaconess Medical Center", 
            "last_name": "Christos Mantzoros, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The primary outcome will be the difference in insulin and leptin tolerance after weight loss", 
            "safety_issue": "No", 
            "time_frame": "8 weeks (10 \u00b1 2% body weight reduction)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01780870"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "We will examine the impact of weight loss on human brain responses to food visualization using functional magnetic resonance imaging (fMRI) and assess whether the baseline CNS signaling has any effect on the ability to lose and maintain weight", 
            "measure": "Difference in brain signaling before and after the 10 \u00b1 2% body weight reduction.", 
            "safety_issue": "No", 
            "time_frame": "8 weeks (10 \u00b1 2% body weight reduction)"
        }, 
        "source": "Beth Israel Deaconess Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beth Israel Deaconess Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}